The End-to-End AI Pipeline

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most transformative shifts in modern drug discovery: the emergence of end-to-end AI-driven pharmaceutical pipelines. Moving beyond isolated applications of artificial intelligence, this episode focuses on how companies like Insilico Medicine are integrating AI across the entire value chain—from target identification to clinical trial design.

Dr. Jagota provides a detailed analysis of Insilico’s Pharma.AI platform, which combines three interconnected engines: PandaOmics for target discovery, Chemistry42 for generative molecular design, and InClinico for predicting clinical trial success. This unified architecture represents a fundamental departure from traditional, fragmented R&D processes, enabling a continuous, data-driven approach to therapeutic development.

The episode highlights a landmark case study: INS018_055 (rentosertib), one of the first drugs fully discovered and designed using AI to reach human clinical trials. Dr. Jagota examines the unprecedented speed and efficiency of its development—achieved in a fraction of the time and cost of conventional methods—as well as its Phase 2a clinical validation, marking a critical proof-of-concept for AI-native drug discovery.

By connecting technological innovation with real-world clinical outcomes, this episode demonstrates how AI is transforming drug development into a predictive, scalable, and economically viable system, redefining both scientific workflows and industry expectations.

For deeper insights, strategic perspectives, and Dr. Jagota’s ongoing work in AI-driven healthcare innovation, please visit: 🌐 https://nirdoshjagota.us/

🌐 https://nirdoshjagota.net/

🌐 https://nirdoshjagota.com/

🌐 https://aboutnirdoshjagota.com/

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(12)

The Quantum Doctor

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores how quantum computing could move beyond pharmaceutical research and into hospitals, diagnostics, genomics, and personalized patient car...

24 Jul 8min

Solving the Unsolvable

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most exciting frontiers in pharmaceutical innovation: quantum simulation. Building on the foundation of quantum computing in...

24 Jul 9min

The Quantum Dawn

In this milestone episode of The Quantum Leap, Dr. Nirdosh Jagota introduces one of the most transformative technologies on the horizon: quantum computing. As artificial intelligence continues to resh...

15 Jun 8min

The New AI Scientist

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most profound shifts in the history of scientific discovery: the emergence of AI as an active research partner. Moving beyon...

15 Jun 9min

The Billion-Dollar Question

In this episode of The Quantum Leap, Dr. Nirdosh Jagota steps beyond the science of AI and quantum computing to explore the financial forces driving the future of medicine. As billions of dollars flow...

3 Jun 12min

The Automated Chemist

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most exciting frontiers in pharmaceutical innovation: the emergence of the self-driving laboratory. While artificial intelli...

3 Jun 12min

Mapping Biology at Scale

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores a fundamental shift in drug discovery—from traditional target-based approaches to a data-first, phenotypic discovery model powered by a...

28 Apr 7min

The Digital Patient

In this episode of The Quantum Leap, Dr. Nirdosh Jagota shifts the focus from molecules to one of the most critical elements in drug development—the patient. He explores how artificial intelligence is...

28 Apr 7min